Sanofi is a French pharmaceutical company created in 2004 by the merger of Sanofi-Synthรฉlabo and Aventis. With sales of EUR 36.1 billion in 2019 and more than 100,000 employees worldwide, Sanofi is one of the largest pharmaceutical companies in the world in terms of sales.
According to Sanofi's latest financial reports the company has a price-to-book ratio of 2.5895.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2025-12-31 | N/A | -100% |
2024-12-31 | 1.51 | -0.62% |
2023-12-31 | 1.52 | 0.7% |
2022-12-31 | 1.51 | -6.23% |
2021-12-31 | 1.61 | -5.66% |
2020-12-31 | 1.70 | -10.22% |
2019-12-31 | 1.90 | 18.86% |
2018-12-31 | 1.60 | 3.32% |
2017-12-31 | 1.54 | -10.37% |
2016-12-31 | 1.72 | -2.24% |
2015-12-31 | 1.76 | -0.61% |
2014-12-31 | 1.77 | -0.94% |
2013-12-31 | 1.79 | 7.55% |
2012-12-31 | 1.66 | 22.77% |
2011-12-31 | 1.36 | 15.21% |
2010-12-31 | 1.18 | -21.23% |
2009-12-31 | 1.49 | 11.35% |
2008-12-31 | 1.34 | -29.55% |
2007-12-31 | 1.90 | -8.25% |
2006-12-31 | 2.08 | -7.48% |
2005-12-31 | 2.24 | 11.73% |
2004-12-31 | 2.01 | -71.07% |
2003-12-31 | 6.94 | -1.26% |
2002-12-31 | 7.03 |
Company | P/B ratio | P/B ratio differencediff. | Country |
---|---|---|---|
![]() Merck MRK | 4.10 | 168.68% | ๐บ๐ธ USA |
![]() Pfizer PFE | 1.46 | -3.95% | ๐บ๐ธ USA |
![]() Bristol-Myers Squibb BMY | 5.65 | 270.28% | ๐บ๐ธ USA |
![]() Novartis NVS | 6.09 | 299.07% | ๐จ๐ญ Switzerland |
![]() GlaxoSmithKline GSK | 4.73 | 209.95% | ๐ฌ๐ง UK |
![]() Teva Pharmaceutical Industries TEVA | 3.26 | 113.59% | ๐ฎ๐ฑ Israel |
![]() Johnson & Johnson JNJ | 4.78 | 213.17% | ๐บ๐ธ USA |
![]() Eli Lilly LLY | 43.6 | 2,760.19% | ๐บ๐ธ USA |
![]() Novo Nordisk NVO | 16.6 | 991.42% | ๐ฉ๐ฐ Denmark |
![]() Abbott Laboratories ABT | 4.74 | 210.64% | ๐บ๐ธ USA |